Arcturus Therapeutics Holdings Inc.
General ticker "ARCT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $312.3M (TTM average)
Arcturus Therapeutics Holdings Inc. does not follow the US Stock Market performance with the rate: -6.8%.
Estimated limits based on current volatility of 2.9%: low 8.30$, high 8.79$
Factors to consider:
- Earnings expected soon, date: 2026-05-11 amc
- Total employees count: 176 (-2.2%) as of 2024
- Top business risk factors: Clinical trial execution risks, Intellectual property risks, Government contract risks, Regulatory and compliance, Operational and conduct risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [4.38$, 11.14$]
- 2026-12-31 to 2027-12-31 estimated range: [4.72$, 11.40$]
Financial Metrics affecting the ARCT estimates:
- Positive: with PPE of -2.7 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -42.61 <= 0.07
- Positive: Investing cash flow per share per price, % of -0.13 > -0.65
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Shareholder equity ratio, % of 78.92 > 64.25
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term ARCT quotes
Long-term ARCT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $157.75MM | $138.39MM | $67.22MM |
| Operating Expenses | $235.95MM | $234.06MM | $142.18MM |
| Operating Income | $-78.20MM | $-95.67MM | $-74.95MM |
| Non-Operating Income | $50.31MM | $14.72MM | $9.17MM |
| Interest Expense | $0.77MM | $0.00MM | $0.00MM |
| R&D Expense | $192.13MM | $195.16MM | $112.21MM |
| Income(Loss) | $-27.89MM | $-80.94MM | $-65.78MM |
| Taxes | $1.83MM | $-0.00MM | $0.00MM |
| Profit(Loss)* | $-29.73MM | $-80.94MM | $-65.78MM |
| Stockholders Equity | $278.51MM | $240.98MM | $213.99MM |
| Assets | $429.40MM | $344.07MM | $271.15MM |
| Operating Cash Flow | $-18.10MM | $-59.75MM | $-74.27MM |
| Capital expenditure | $2.90MM | $0.65MM | $0.23MM |
| Investing Cash Flow | $-2.90MM | $-0.65MM | $-0.23MM |
| Financing Cash Flow | $-24.09MM | $5.42MM | $13.38MM |
| Earnings Per Share** | $-1.12 | $-3.00 | $-2.40 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.